143 related articles for article (PubMed ID: 9559831)
1. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
[No Abstract] [Full Text] [Related]
2. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
4. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Perez-Trallero E; Urbieta M; Montes M; Ayestaran I; Marimon JM
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):25-31. PubMed ID: 9512178
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
[TBL] [Abstract][Full Text] [Related]
7. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
Chen I; Kaufisi P; Erdem G
J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
[TBL] [Abstract][Full Text] [Related]
8. Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
Perez-Trallero E; Garcia C; Orden B; Marimon JM; Montes M
Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):123-6. PubMed ID: 14712367
[TBL] [Abstract][Full Text] [Related]
9. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
[TBL] [Abstract][Full Text] [Related]
11. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Masala L; Lo Cascio G; Orefici G; Fontana R
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S87-92. PubMed ID: 9710676
[TBL] [Abstract][Full Text] [Related]
12. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin resistance of Streptococcus pyogenes in Madrid.
Orden B; Perez-Trallero E; Montes M; Martínez R
Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of Streptococcus pyogenes to penicillin, macrolides and clindamycin in Cádiz].
Marín P; Márquez A; García-Martos P; García-Tapia A; Tapia J
Rev Esp Quimioter; 2000 Sep; 13(3):318-9. PubMed ID: 11086284
[No Abstract] [Full Text] [Related]
15. The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
Ferraro AL; Mortensen JE; Blecker DL; Phengvath C
Adv Exp Med Biol; 1995; 390():119-21. PubMed ID: 8718607
[No Abstract] [Full Text] [Related]
16. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus.
Dipersio LP; Dipersio JR
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):189-93. PubMed ID: 16989973
[TBL] [Abstract][Full Text] [Related]
17. Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children.
Zachariadou L; Papaparaskevas J; Paraskakis I; Efstratiou A; Pangalis A; Legakis NJ; Tassios PT
Clin Microbiol Infect; 2003 Apr; 9(4):310-4. PubMed ID: 12667242
[TBL] [Abstract][Full Text] [Related]
18. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
19. Erythromycin resistance in Streptococcus pyogenes in Italy.
Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
